TECHNETIUM TC-99M SULFUR COLLOID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Technetium Tc-99m Sulfur Colloid, and when can generic versions of Technetium Tc-99m Sulfur Colloid launch?
Technetium Tc-99m Sulfur Colloid is a drug marketed by Jubilant and is included in one NDA.
The generic ingredient in TECHNETIUM TC-99M SULFUR COLLOID is technetium tc-99m sulfur colloid kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m sulfur colloid kit profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Technetium Tc-99m Sulfur Colloid
A generic version of TECHNETIUM TC-99M SULFUR COLLOID was approved as technetium tc-99m sulfur colloid kit by JUBILANT on November 9th, 2023.
Summary for TECHNETIUM TC-99M SULFUR COLLOID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TECHNETIUM TC-99M SULFUR COLLOID at DailyMed |
Recent Clinical Trials for TECHNETIUM TC-99M SULFUR COLLOID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
OnLume Inc. | Early Phase 1 |
National Cancer Institute (NCI) | Early Phase 1 |
University of Wisconsin, Madison | Early Phase 1 |
US Patents and Regulatory Information for TECHNETIUM TC-99M SULFUR COLLOID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jubilant | TECHNETIUM TC-99M SULFUR COLLOID KIT | technetium tc-99m sulfur colloid kit | SOLUTION;INJECTION, ORAL | 213516-001 | Nov 9, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |